Aurora Cannabis Facility Receives EU GMP Certification
In addition, Aurora has received all necessary approvals from local regulators in Germany for sales of its medical cannabis products, following a temporary sales suspension on certain products in December 2019. Aurora will fulfill existing sales orders from inventory currently held in Germany, ensuring local patients will have immediate access to medicine from their preferred pharmacy.
“Aurora is leading the development of medical markets across Europe and around the world,” said Terry Booth, CEO of Aurora. “The EU GMP certification of our River facility further validates our strategy focused on purpose-built facilities, designed and constructed exclusively for the production of high-quality, pharmaceutical grade cannabis. I congratulate our team on successfully working with regulators and licensing bodies to ensure Aurora’s facilities and products are in accordance with local and international standards that will allow for greater access to the highest quality medical cannabis products to patients who need them.”
To date, Aurora has received EU GMP certification for three of its 10 Canadian production facilities. Aurora River joins Aurora Mountain, located in Mountain View County, Alberta, with a production capacity of 4,800 kg a year, and Aurora Ridge located in Markham, Ontario with a production capacity of 7,000 kg a year, in achieving this important certification.